Investor Stock List
Ranked #1,638 of 8,699 institutional investors

Sofinnova Investments, Inc.

Menlo Park, CA

$1.78B
US stock portfolio at live prices · today +$2.2M (+0.12%)
Market closed. Prices as of Nov 20, 8:11 AM ET
Value at quarter end (Q3 2026)
$2.03B
Change from Q2 2026
+$154.7M (+8.26%)
Positions
54 · 12 new, 6 sold out
Filed
Nov 16, 2026

Not counted in the ranking: call options on $46.0M of stock, put options on $229M. $217M of holdings we could not match to a US listing are included at their reported quarter-end value.

Holdings

Q3 2026 13F, live prices
NTRA 25.3%GMAB 12.6%VERA 4.20%SPTX 3.67%RYTM 3.51%
StockSharesValue, live% of portfoliovs Q2 2026
NTRA Natera, Inc.1,550,280$449M25.3%Unchanged
GMAB Genmab A/S4,349,551$223M12.6%Added +8%
VERA Vera Therapeutics, Inc.2,793,987$74.7M4.20%Unchanged
SPTX Seaport Therapeutics, Inc.3,564,871$65.3M3.67%Unchanged
RYTM Rhythm Pharmaceuticals, Inc.534,538$62.4M3.51%Added +31%
AXSM Axsome Therapeutics, Inc.445,906$60.5M3.40%Added +178%
LLY Eli Lilly and Company43,777$59.1M3.33%New
RAPP Rapport Therapeutics, Inc.1,904,408$44.9M2.53%Unchanged
DYN Dyne Therapeutics, Inc.2,511,006$40.3M2.26%Added +51%
RARE Ultragenyx Pharmaceutical Inc.1,753,703$30.2M1.70%Added +2%
NVS Novartis AG196,700$29.7M1.67%New
INBX Inhibrx Biosciences, Inc.391,621$29.1M1.64%Added +29%
IMNM Immunome, Inc.1,627,469$27.0M1.52%Reduced −5%
BMRN BioMarin Pharmaceutical Inc.432,695$26.6M1.50%Added +21%
IDYA IDEAYA Biosciences, Inc.946,340$24.8M1.39%Added +2%
ABT Abbott Laboratories207,000$21.5M1.21%Added +68%
UTHR United Therapeutics Corporation36,491$20.4M1.15%Reduced −52%
IDXX IDEXX Laboratories, Inc.29,145$20.1M1.13%New
BMY Bristol-Myers Squibb Company329,967$19.3M1.08%Reduced −62%
AVBP ArriVent BioPharma, Inc.1,696,752$19.1M1.07%Unchanged
MANE Veradermics Inc144,054$17.9M1.01%Reduced −3%
IRON Disc Medicine, Inc.231,628$17.6M0.99%Added +58%
TRAX First Tracks Biotherapeutics, Inc.383,588$17.1M0.96%Reduced −32%
ALNY Alnylam Pharmaceuticals, Inc.112,879$16.7M0.94%New
EWTX Edgewise Therapeutics, Inc.396,598$16.3M0.92%Added +4%
ANAB AnaptysBio, Inc.330,396$15.7M0.88%Reduced −33%
BIIB Biogen Inc.63,002$15.6M0.88%New
BIOA BioAge Labs, Inc.2,293,788$10.8M0.61%Unchanged
DSGN Design Therapeutics, Inc.1,144,827$10.7M0.60%Added +32%
DFTX Definium Therapeutics, Inc.339,018$10.0M0.56%Added +32%
RCUS Arcus Biosciences, Inc.626,178$9.9M0.56%Reduced −34%
ERAS Erasca, Inc.677,041$9.6M0.54%New
TARS Tarsus Pharmaceuticals, Inc.110,108$8.6M0.48%New
NRIX Nurix Therapeutics, Inc.523,673$7.1M0.40%Unchanged
NKTR Nektar Therapeutics217,963$7.1M0.40%Reduced −54%
SLN Silence Therapeutics plc211,802$4.2M0.24%New
MIRM Mirum Pharmaceuticals, Inc.19,450$1.9M0.10%Reduced −30%
SVRA Savara Inc.356,224$1.9M0.10%Reduced −2%
SEPN Septerna, Inc.46,217$1.8M0.10%Reduced −3%
JBIO Jade Biosciences, Inc.107,391$1.6M<0.1%Unchanged
SGMT Sagimet Biosciences Inc.162,380$1.6M<0.1%Reduced −3%
NXTC NextCure, Inc.222,654$1.5M<0.1%Unchanged
PAHC Phibro Animal Health Corporation43,216$1.5M<0.1%New
PRAX Praxis Precision Medicines, Inc.3,703$1.2M<0.1%Reduced −43%
OKUR OnKure Therapeutics, Inc.312,553$863K<0.1%Reduced −3%
IVA Inventiva S.A.209,500$723K<0.1%New
BOLT Bolt Biotherapeutics, Inc.137,721$697K<0.1%Unchanged
ABSI Absci Corporation80,817$659K<0.1%Reduced −76%
TYRA Tyra Biosciences, Inc.31,407$620K<0.1%Reduced −3%
AKTS Aktis Oncology, Inc.31,605$518K<0.1%Reduced −3%
WVE Wave Life Sciences, Inc.184,825$503K<0.1%Reduced −2%
IBIO iBio, Inc.371,700$298K<0.1%New
LSTA Lisata Therapeutics, Inc.156,460$142K<0.1%New
IMA ImageneBio, Inc.31,884$127K<0.1%Unchanged

Sold out in Q3 2026

StockShares held at Q2 2026Worth today
GILD Gilead Sciences, Inc.343,100$57.1M
COGT Cogent Biosciences, Inc.1,035,148$28.7M
INSM Insmed Incorporated158,398$22.9M
TENX Tenax Therapeutics, Inc.500,039$695K
SION Sionna Therapeutics, Inc.144,432$429K
HTFL Heartflow, Inc.5,079$227K